Value Investing News

Investor powered stock market news
  • Home
  • Blog
  • Advertise
  • Contact
  • Privacy Policy
  • Submit Story
  • Review New Stories
    • Rising stories
    • Your recommendations
  • Top Stories
    • This day
    • This week
    • This month
    • This year
    • All time
  • Tools
    • Directory
    • Screener
    • Search
    • VIN Toolbar
  • Community
    • Festival of Stocks
    • Forum
    • Member profiles
  • Offers
  • Join
  • Forgot?
Home » Story links » moneymaven's story links

Pharma, the best of

By moneymaven on Fri, 2010-01-08 12:02
  • Stock Analysis
  • ABT
  • BMY
  • CELG
  • JNJ
  • MRK
  • PFE
(via www.equithive.com)

the best of pharma - Johnson & Johnson valuation compared against, Celgene, Pfizer, Abbott Laboratories, Merck and Bristol Myers Squibb

  • http://www.equithive.com/Main/Report/148/JNJ.rpt (137)

Shared: 
Twitter: LinkedIn: Facebook:
  • Login or register to post comments
  • 1 vote

Related News

  • JNJ valuation and competetive analysis
  • The best dividend payers
  • Johnson & Johnson (JNJ) Dividend Stock Analysis | Dividends Value
  • Johnson & Johnson (JNJ):the best dividend stock
  • Using Magic Formula Investing to Rank any List of Stocks
  • Dividend Growth Stocks: Abbott Laboratories (ABT) Dividend Stock Analysis
  • Dividend Growth Stocks: Johnson & Johnson (JNJ) Dividend Stock Analysis

Recent comments

  • Wow, I am grateful for
    12 hours 43 min ago
  • Great Job !
    4 days 14 hours ago
  • There are many chain link fence suppliers, and choosing the best
    5 days 18 hours ago
  • Sweet blog! I discovered it
    1 week 6 days ago
  • This is really interesting,
    1 week 6 days ago
  • I think that you could do
    2 weeks 15 hours ago
  • I think that you could do
    2 weeks 16 hours ago
  • I will be happy for the
    2 weeks 1 day ago
  • You understand therefore
    2 weeks 2 days ago
  • You understand therefore
    2 weeks 2 days ago

New forum topics

  • Atlantic International Partnership Headlines: Best Places to Sell Your Gold Coins for Most Profit
  • New here
  • Norton Medical and Scientific Research & Biotechnology - FDA approves kidney cancer drug from Pfizer
  • Norton Scientific Collection: Terms and Conditions - Norton Collection of Classic and Scientific Literature
  • Norton Medical and Scientific Research & Biotechnology - FDA approves kidney cancer drug from Pfizer
more

Explore

  • Behavioral Finance
  • Bonds
  • Commentary
  • Digest
  • Education
  • Filings
  • Funds
  • International
  • Reviews
  • Shareholder Activism
  • Stock Analysis
  • Superinvestors
  • Tools
  • Stocks
  • Value Investing Forum
  • Videos
  • VIN Blog

Most Read this Week

  1. Recent Walter Schloss Presentation All About Ben Graham
  2. Donald Yacktman Buys Financials
  3. Longleaf Partners Letter to Shareholders 2011
  4. Rules for net-net investing
  5. Letter from Mark Zuckerberg: Dear Facebook Employees

  • Home
  • Blog
  • Advertise
  • Contact
  • Privacy Policy
Copyright © 2006 - 2011 Fat Pitch Financials LLC. All rights reserved.